Effect of somatostatin on postprandial gallbladder relaxation.
Although the inhibitory effect of somatostatin (SST) on gallbladder contraction is well known, the influence of SST on gallbladder motility during the late postprandial or relaxation phase has not been studied. We therefore investigated the effect of SST on gallbladder relaxation and gut hormone release during the late postprandial phase. Eight healthy volunteers participated in two experiments performed in random order during continuous infusion of either SST or saline (placebo) starting 2 h after meal ingestion. At regular intervals, gallbladder volumes were measured (ultrasonography) and blood samples were taken for determination of plasma cholecystokinin (CCK), pancreatic polypeptide (PP), peptide YY (PYY) and neurotensin levels (radioimmunoassay). Postprandial gallbladder contraction was similar in both experiments: 68 +/- 4% vs. 66 +/- 4%. During SST infusion, postprandial gallbladder contraction was significantly (P<0.01) reduced (2874 +/- 813% *240 min) compared with saline (9391 +/- 1595% *240 min). Plasma CCK, PP, PYY and neurotensin levels were in the same range in the early postprandial phase but were significantly reduced during SST infusion compared with placebo (late postprandial phase). Plasma levels of CCK correlated with gallbladder volumes during both the contraction and relaxation phase (r=0.68, P=0.01 and r=0.61, P=0.008, respectively). SST enhances gallbladder relaxation and reduces hormone secretion in the late postprandial phase. The results point to an association between CCK and gallbladder volume not only during the postprandial contraction phase but also during the relaxation phase.
Vu
M K
MK
Department of Gastroenterology-Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
Van Oostayen
J A
JA
Biemond
I
I
Masclee
A A
AA
D000328:Adult; D002766:Cholecystokinin / Q000097:blood; D005260:Female; D016473:Gallbladder Emptying / Q000187:drug effects* / Q000502:physiology*; D006728:Hormones / Q000008:administration & dosage*; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008297:Male; D009496:Neurotensin / Q000097:blood; D010191:Pancreatic Polypeptide / Q000097:blood; D019894:Peptide YY / Q000097:blood; D019518:Postprandial Period / Q000502:physiology; D013004:Somatostatin / Q000008:administration & dosage*
D006728:Hormones; D019894:Peptide YY; D009496:Neurotensin; D013004:Somatostatin; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin